Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Gupta, Charu, Kaulfuss, Stefan, Görlich, Kerstin, Othman, Basem, Chaturvedi, Anuhar, Heuser, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237524/
https://www.ncbi.nlm.nih.gov/pubmed/32296913
http://dx.doi.org/10.1007/s00277-020-04001-w
_version_ 1783536334261977088
author Gupta, Charu
Kaulfuss, Stefan
Görlich, Kerstin
Othman, Basem
Chaturvedi, Anuhar
Heuser, Michael
author_facet Gupta, Charu
Kaulfuss, Stefan
Görlich, Kerstin
Othman, Basem
Chaturvedi, Anuhar
Heuser, Michael
author_sort Gupta, Charu
collection PubMed
description
format Online
Article
Text
id pubmed-7237524
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-72375242020-05-27 Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia Gupta, Charu Kaulfuss, Stefan Görlich, Kerstin Othman, Basem Chaturvedi, Anuhar Heuser, Michael Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2020-04-15 2020 /pmc/articles/PMC7237524/ /pubmed/32296913 http://dx.doi.org/10.1007/s00277-020-04001-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Gupta, Charu
Kaulfuss, Stefan
Görlich, Kerstin
Othman, Basem
Chaturvedi, Anuhar
Heuser, Michael
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
title Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
title_full Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
title_fullStr Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
title_full_unstemmed Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
title_short Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
title_sort combination treatment of an idh1 inhibitor with chemotherapy in idh1 mutant acute myeloid leukemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237524/
https://www.ncbi.nlm.nih.gov/pubmed/32296913
http://dx.doi.org/10.1007/s00277-020-04001-w
work_keys_str_mv AT guptacharu combinationtreatmentofanidh1inhibitorwithchemotherapyinidh1mutantacutemyeloidleukemia
AT kaulfussstefan combinationtreatmentofanidh1inhibitorwithchemotherapyinidh1mutantacutemyeloidleukemia
AT gorlichkerstin combinationtreatmentofanidh1inhibitorwithchemotherapyinidh1mutantacutemyeloidleukemia
AT othmanbasem combinationtreatmentofanidh1inhibitorwithchemotherapyinidh1mutantacutemyeloidleukemia
AT chaturvedianuhar combinationtreatmentofanidh1inhibitorwithchemotherapyinidh1mutantacutemyeloidleukemia
AT heusermichael combinationtreatmentofanidh1inhibitorwithchemotherapyinidh1mutantacutemyeloidleukemia

Ejemplares similares